Feng Shao
邵峰
Feng Shao is a Chinese academician and biotech entrepreneur. After completing his PhD in 2003, he spent just over a year as a postdoctoral researcher at Harvard Medical School . He later co-founded Yanming Biotech (炎明生物, also known as Pyrotech Therapeutics), partnering with Dr. Deng Tianjing; the company was already noted in FreeS Capital's portfolio tracking by mid-2021 and again in mid-2024 .
elsewhere's corpus does not cover this subject in depth — no dedicated profile pieces were retrieved, and the available material is limited to these sparse biographical and venture references from FreeS Capital's funding newsletters and one 2020 interview.
AI-generated — may contain errors, please verify.
Coverage
New Listings and New Funding: 10 Developments in the Height of Summer | FreeS Family Funding News Vol.19
Looking forward to working alongside more outstanding founders.
峰瑞资本·FreeS Family Funding News · July | PatPat, Yanming Biotech, Qbit, and Innostar Secure Financing
We've also released three short videos this issue — follow us to check them out.
峰瑞资本·Li Feng in Conversation with Academician Shao Feng: New Trends in Drug Discovery
How Can Basic Research Better Connect with Industry in Biomedicine, a Field Where "the Barrier to Entry Is Low, but the Courtyard Runs Deep"?
峰瑞资本·Li Feng in Conversation with Academician Shao Feng: First In Class in China | Last 2 Days to Register
How can basic biomedical research better connect with industry?
峰瑞资本·Beyond the "Narrow Door": A Real-World Portrait of Early-Stage Frontier Biotech Entrepreneurship in China | FreeS Fund 2020 Biotech Summit Registration Now Open
Will Today’s US Biotech Become China’s Tomorrow?
峰瑞资本·Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
峰瑞资本·





